Arrowhead Pharmaceuticals ARWR
$ 19.23
-2.44%
Quarterly report 2024-Q2
added 08-08-2024
Arrowhead Pharmaceuticals General and Administrative Expenses 2011-2024 | ARWR
Annual General and Administrative Expenses Arrowhead Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
92.5 M | 124 M | 81 M | 52.3 M | 26.6 M | 19.1 M | 32 M | 41 M | 34.7 M | 24.4 M | 11.7 M | 14.1 M | 5.23 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
124 M | 5.23 M | 43 M |
Quarterly General and Administrative Expenses Arrowhead Pharmaceuticals
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
23.7 M | 25.1 M | 23.6 M | - | 23.8 M | 23.2 M | 21 M | - | 33.1 M | 34.3 M | 25 M | - | 18.4 M | 16.3 M | 8.8 M | 38 M | 10.7 M | 8.8 M | 10.9 M | 16.3 M | 4.81 M | 10.9 M | 6.14 M | 12.7 M | 4.59 M | 6.14 M | 4.4 M | 12.1 M | 3.92 M | 1.67 M | 1.85 M | 8.05 M | 2.28 M | 1.85 M | 1.95 M | 5.61 M | 1.83 M | 1.95 M | 2.09 M | 3.87 M | 1.58 M | 2.09 M | 914 K | 2.6 M | 900 K | 914 K | 918 K | 5.34 M | 3.14 M | 918 K | 1.27 M | 2.08 M | 637 K | 1.28 M |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
38 M | 637 K | 9.5 M |